HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
LSE:HCM
Price:
313 GBX
1.62%
Market Closed
Updated:
May 9, 2024
HUTCHMED (China) Ltd
Cash from Operating Activities
|
HUTCHMED (China) Ltd
Cash from Operating Activities Peer Comparison
Comparables:
G
512
U
3933
S
1177
C
570
C
3320
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Operating Activities
$219.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
46%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Cash from Operating Activities
HK$1.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Operating Activities
¥2.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Operating Activities
¥5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
15%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Operating Activities
¥221.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
10%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Operating Activities
HK$10.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Cash from Operating Activities?
Cash from Operating Activities
219.3m
USD
219.3m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Cash from Operating Activities amounts to 219.3m USD.
What is HUTCHMED (China) Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
46%
46%
You don't have any saved screeners yet
